問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
葉建宏
下載
2025-02-01 - 2027-12-31
Condition/Disease
● Evaluate the safety and tolerability of DNTH103 in patients with generalized myasthenia gravis (gMG) up to week 13.
Test Drug
DNTH103 150 mg/mL
Participate Sites8Sites
Recruiting8Sites
2021-01-01 - 2029-07-31
2022-06-15 - 2029-09-30
Participate Sites4Sites
Recruiting4Sites
2021-07-14 - 2029-05-31
2024-04-01 - 2030-12-31
2021-11-01 - 2028-11-11
Participate Sites5Sites
Recruiting5Sites
2023-12-01 - 2026-12-12
Participate Sites2Sites
Recruiting2Sites
2025-01-01 - 2030-12-31
2023-01-01 - 2027-12-31
2023-01-16 - 2025-08-30
Participate Sites23Sites
Recruiting13Sites
Terminated5Sites
全部
